MedTrace Logo

Intra-articular Allocetra in Osteoarthritis of the of the Temporomandibular Joint (TMJ)

NCT06748651 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2024-12-27

No results posted yet for this study

Summary

This study is a single center trial to assess the safety and initial efficacy of intra-articular administration of Allocetra to patients with Temporomandibular Joint Osteoarthritis (TMJ-OA)

Conditions

  • Temporomandibular Joint Osteoarthritis

Interventions

DRUG

Allocetra

Intra-articular injection of Allocetra performed once on Day 1 of the study

Sponsors & Collaborators

  • Sheba Medical Center

    collaborator OTHER_GOV

  • Dr. Amit Druyan

    lead OTHER_GOV

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-15
Primary Completion
2026-02-07
Completion
2026-04-08

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06748651 on ClinicalTrials.gov